Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Recent publications published by researchers at the MRC WIMM.

Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms.

Chowdhury O. et al, (2021), Br J Haematol, 194, 1010 - 1015

Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide.

Chowdhury O. et al, (2021), Leukemia, 35, 1197 - 1202

Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide

Chowdhury O., (2020), Leukemia

Evaluation of the detection of B-cell clonal lymphoproliferative disorders by flow cytometry or cytological analysis in lymph node aspirates obtained by endobronchial ultrasound

Lomas O. et al, (2019), BRITISH JOURNAL OF HAEMATOLOGY, 185, 93 - 94

Spliceosome Mutations Are Common in MPN-Associated Myelofibrosis with RBC-Transfusion-Dependence and Correlate with Response to Pomalidomide

Chowdhury O. et al, (2018), BLOOD, 132

Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD-induced myeloproliferation.

Mead AJ. et al, (2017), J Exp Med, 214, 2005 - 2021

Autophagy limits proliferation and glycolytic metabolism in acute myeloid leukemia.

Watson AS. et al, (2015), Cell Death Discov, 1

Erratum to Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo, [Cancer Cell, 25, 2014, 794-808]

Woll PS. et al, (2015), Cancer Cell, 27, 603 - 605

A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine.

Svensson T. et al, (2014), Eur J Haematol, 93, 439 - 445

Erratum to Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo [Cancer Cell, 25 (2014) 794-808]

Woll PS. et al, (2014), Cancer Cell, 25

Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo

Woll PS. et al, (2014), Cancer Cell, 25, 794 - 808

Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.

Woll PS. et al, (2014), Cancer Cell, 25, 794 - 808

THIRD GENERATION AUTOLOGOUS MYELOID-DERIVED DENDRITIC CELLS DEVELOPED FROM PATIENTS WITH CMML AND MDS DEMONSTRATE PHENOTYPIC PROPERTIES OF MATURE FUNCTIONAL DENDRITIC CELLS

Anderson K. et al, (2014), CYTOTHERAPY, 16, S24 - S25

THIRD GENERATION AUTOLOGOUS MYELOID-DERIVED DENDRITIC CELLS DEVELOPED FROM THE PATIENTS WITH CMML AND NON-CML SUBTYPES OF MDS DEMONSTRATE PHENOTYPIC PROPERTIES OF MATURE FUNCTIONAL DC

Anderson K. et al, (2014), BONE MARROW TRANSPLANTATION, 49, S138 - S138

A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine

Svensson T. et al, (2014), European Journal of Haematology, 93, 439 - 445

Characterisation of the Stem and Progenitor Cell Hierarchy in Patients with CMML

Chowdhury O. et al, (2014), BLOOD, 124

FLT3-ITD INDUCED MYELOPROLIFERATION CAUSES A CELL EXTRINSIC DEPLETION OF HAEMATOPOIETIC STEM CELLS

Mead AJ. et al, (2014), HAEMATOLOGICA, 99, 256 - 256

Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy.

Sanjuan-Pla A. et al, (2013), Nature, 502, 232 - 236

Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia

Fisher SA. et al, (2013), Cochrane Database of Systematic Reviews, 2017

Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.

Fisher SA. et al, (2013), Cochrane Database Syst Rev

Load More

Include forthcoming?